Some people are getting shut out when it comes to GLP-1 drugs. Here’s why.

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

Coverage (5)

• Controversy surrounding diabetes drug, Ozempic, being used for weight loss LiveNOW from FOX · 2h ago
• The billion-dollar problem keeping Ozempic, Wegovy, and Zepbound from patients ScienceDaily · 2h ago
• The GLP-1 paradox: too expensive to cover, too effective to cut Fortune · 2h ago
• CEO of major Mass. health insurer discusses choice to restrict GLP-1 weight-loss drugs The Boston Globe · 2h ago
• Some people are getting shut out when it comes to GLP-1 drugs. Here’s why. The Washington Post · 2h ago

From around our network

• Why Some People Get Motion Sick and Others Almost Never Do daybreakwire.com

Related trends